The photocytotoxic effect of UVA-excited titanium dioxide (TiO 2 ), which is caused by the generation of reactive oxygen species (ROS), is often used in medical applications, such as cancer treatment.
Introduction
Titanium dioxide (TiO 2 ) is frequently used in biomedical applications and food technologies due to its high chemical inertness, low toxicity, physical stability and commercial availability.
1 Upon UV illumination, TiO 2 is excited, leading to the production of toxic Reactive Oxygen Species (ROS) 2,3 which play important roles in the photocatalytic reaction mechanism. Photodynamic-therapy (PDT) utilizes ROS production by TiO 2 for the treatment of several proliferating skin diseases, 5 such as vitiligo 6 and psoriasis, using UVB and UVA radiation. 7, 8 UV illumination of TiO 2 nanoparticles (NPs), has been also used for PDT in several types of cancer, 9-14 including melanoma.
15
Cutaneous melanoma (CM), which is one of the most rapidly growing cancers worldwide, 16 is of a serious public health concern, given the substantial burden associated with the disease. 17 Currently CM is treated by surgery, chemotherapy and radiation therapy as well as targeted-and immuno-therapies. 18 In cases of advanced melanoma (stages III and IV) PDT may be used, oen in combination with surgery 19 and was shown to regress melanoma metastasis. 20 However, the lack of specicity towards cancer cells limits the applicability of this approach due to potential damage to the surrounding healthy cells. 21 This limitation may be overcome by preferentially directing the TiO 2 NPs towards cancer cells.
Integrins are a family of cell surface receptors which are overexpressed on tumor cells. Twenty-four integrin heterodimers were identied and consist of a combination between at least 18 a-subunits and 8 b-subunits. 22 These receptors play a key role in the cross-talk between the cell and its surrounding stroma via an Arg-Gly-Asp (RGD) recognition motif and offer a docking site for endothelial, inammatory and cancer cells. 23 Integrin avb 3 serves as an attractive and a rational target for anticancer drug delivery, 24, 25 including in melanoma. 26, 27 In order to increase the selectivity of PDT towards cancer cells, efforts on developing integrin-targeted drug-delivery tools using TiO 2 -RGD nanocomplexes were recently reported. 28 We propose an alternative delivery approach, which is based on the tendency of TiO 2 to adsorb to proteins. 29 Our laboratory has identied the human protein dihydrolipoamide dehydrogenase (DLDH), which strongly and specically binds TiO 2 via coordinative bonds.
30-32
Bioengineering this protein with RGD moieties and attaching it to TiO 2 NPs led to the formation of a hybrid-conjugate nanobiocomplex (TiO 2 -DLDH RGD ), offering integrin-targeted drug delivery. In this work we present a "switchable" nanomedicine which is activated by UVA illumination to produce ROSdepended cytotoxicity in integrin-expressing melanoma cancer cells, while normal cells with low integrin expression remain less affected (Scheme 1).
2 Experimental section
Materials
All reagents and carriers were of analytical grade and were purchased from Sigma-Aldrich (St. Louise, MO), unless otherwise specied. P25 NPs were purchased from Degussa Chemicals (Hanau, Germany).
Tissue culture media and cell lines were purchased from Biological Industries (Bet-Haemek, Israel), unless otherwise specied. B16F10 mouse cutaneous melanoma cells (ATCC, CRL-6475) and human normal embryonic kidney cells, HEK293 (ATCC CRL1573) were cultured in RPMI 1640 medium, supplemented with 10% (v/v) heat inactivated fetal calf serum, 2 mM L-glutamine and antibiotics (penicillin/streptomycin), in a humidied atmosphere of 5% CO 2 at 37 C. The cells were shown to be mycoplasma negative. or Anatase), stirred with a micro magnetic bar. The wells were exposed to a UVA light source for up to 150 minutes. Dark conditions in the control wells were obtained by covering the wells with aluminum foil. One ml samples were withdrawn and the TiO 2 -NPs sedimented by centrifugation (Heraeus, Thermo Fisher Scientic, Waltham, MA) at 17 800g for 15 minutes. Optical densities of the supernatants (0.5 ml) were determined at 663 nm by a Genesys 10S UV-VIS spectrometer (Thermo Fisher Scientic, Waltham, MA). 2.7.2 Cytochrome C reduction assay. Cytochrome C (Cyt-C) reduction assay was carried out in a 24 well plate, each well containing 2 ml of oxidized Cyt C solution (0.1 mM of Cyt-C in PBS buffer, pH 7.4) and 0-0.8 mg of anatase NPs (A-NPs), stirred with a micro magnetic bar. The wells were exposed to a light source for up to 30 minutes. Dark conditions in the control wells were obtained by covering the wells with aluminum foil. One ml samples were withdrawn and the A-NPs were sedimented by centrifugation (Heraeus, Thermo Fisher Scientic, Waltham, MA) at 17 800g for 15 minutes. Optical densities of the supernatants (0.5 ml) were examined at 450 and 550 nm by a Genesys 10S UV-VIS spectrometer ( Confocal microscopy. Cells were visualized by a uo-rescence confocal microscope (Leica, SP5, Mannheim, Germany) with bright eld or excitation at 647 nm and emission at 681-697 nm. The images were obtained using immersion oil (Â63) objective. Images constructed using Leica Application Suite Advanced Fluorescence Lite version 2.6.3 build 8173 soware.
2.8.4 Absolute cell number determination. The cells were harvested in a xed volume and counted using an automated cell counter -TC20™ (BIO-RAD, Hercules, CA).
Statistical analysis
All data are expressed as means AE standard error of the mean. Signicant differences were assessed by P value.
3 Results and discussion
Anatase TiO 2 NPs is the most photoreactive form
In this section we aimed to study the TiO 2 physicochemical photocatalytic activity in order to dene the optimal TiO 2 forms which possess the highest surface area and ROS activity of the titanium dioxide molecules. For that, several types of TiO 2 (anatase, rutile, amorphous) at different forms (disks, nanotubes, nano-particles) were examined. The different TiO 2 preparations were assessed for ROS production using Methylene Blue (MB) photodegradation. Results indicate that the most active TiO 2 form is the anatase nanoparticles (A-NPs) (Fig. S-1 †) .
As nanoparticles possess the highest surface areas, and provide advantages due to their small size, permeability, high surface ratio and retention, 34 we have focused on several TiO 2 NPs and compared the photoreactivity of the A-NPs with two additional TiO 2 forms, P-25 and rutile nanoparticles upon UVA illumination. For that, two methods were used to measure ROS production, MB photo degradation and cytochrome C (Cyt C) reduction. The highest rate of MB degradation (Fig. 1A) was observed with the A-NPs. Photoexcitability of rutile NPs was dramatically lower, while P25 showed an effect that was slightly lower compared to the A-NPs form. Illumination under UVA without Ti-NPs showed very low degree of photolysis. These results are in accord with reports of a higher surface activity of anatase, compared to rutile. 35, 36 To note, light at 365 nm wavelength was shown to penetrate dipper to the epidermis and dermis, compared to other UV rays 37 and is therefore suitable for PDT treatments in melanoma cells.
37-39
Next, we set to measure the A-NPs ROS generation by Cyt C reduction assay under the same illumination conditions. Optimization of A-NPs concentration in the ROS generation assay for 30 min is shown in Fig. 1B . Based on this experiment 0.4 mg ml À1 of A-NPs was chosen to study the rate of ROS production over time (Fig. 1C) . To note, similar ROS production was observed by A-NPs in different buffers, including cell culture media ( Fig. S-2 
43,44
In contrast, we have reported the ability of DLDH to bind TiO 2 31,32 via strong coordinative bonds. 30 These strong binding of DLDH to TiO 2 , has been thoroughly investigated by our group and was shown to be reversed only in the presence of high molar urea concentrations. [30] [31] [32] We have modied DLDH monomer with GRGDSP moieties at the N-and C-termini, thus creating a dimer of DLDH with four RGD moieties (DLDH RGD ). This GRGDSP sequence was shown to specically interact with avb3 integrins. 45, 46 The RGD-modied DLDH is expected to serve as a molecular bridge and facilitate targeted-delivery of TiO 2 to integrin-expressing cancer cells. Examination of the amounts of protein bound to TiO 2 NPs revealed that comparable TiO 2 binding capabilities were observed for DLDH before and aer RGD modication.The RGD-modied DLDH is expected to serve as a molecular bridge and facilitate targeted-delivery of TiO 2 to integrin-expressing cancer cells. Examination of the amounts of protein bound to TiO 2 NPs revealed that comparable TiO 2 binding capabilities were observed for DLDH before and aer RGD modication. We intended to study which of the different TiO 2 NPs (A-NPs, rutile and P25) bind DLDH most efficiently. In addition, we aimed to study the effect of the RGD-modication on the binding capabilities of DLDH. The NPs structure of anatase ( Fig. 2A), rutile (Fig. 2B) and P25 (Fig.  2C) . Considering the molecular diameter of about 6.7 nm for the hDLDH dimer and the average pore size reported for P25 (8.3 nm), the protein is expected to bind mostly to the outer surface of the TiO 2 particles. 30 Taken together, it was shown that A-NPs posess higher photocatalytic activity upon UVA illumination, while retaining DLDH RGD binding capabilities. As integrins are highly expressed on the surface of tumor cells, the A-NPs-DLDH RGD nanobiocomplex may serve as a novel integrin-drug delivery PDT strategy in this disease.
Optimization of the A-NPs-DLDH RGD nanobiocomplex components in mice melanoma cells under UVA illumination or in the dark
Following the design and characterization of the TiO 2 -DLDH RGD nanobiocomplex, we aimed to optimize our formulation in vitro for PDT. We used mice cutaneous melanoma cells (B16F10) which highly express integrin avb3 on their surface.
47
The cells (50 000 cells/24 well plates) were treated with different amounts of A-NPs (0À5 mg ml À1 ) conjugated to 50 mg DLDH RGD , with increasing TiO 2 -protein ratios. The cell nuclei are indicated by a red color (Draq5 stain). The cells were incubated with the sediment of the nanobiocomplex for 1h in the dark or under UVA illumination (365 nm), following an incubation for an overnight. The cells were incubated for an overnight and the next day were visualized using confocal microscopy. Results show that in the dark the cells remained intact (Fig. 3, upper panel) . Following UVA illumination, a substantial amount of nuclear shredding, indicative of apoptosis, was shown with increasing nanobiocomplex ratio (Fig. 3, lower panel) . This indicates that UVA illumination is essential for the activation of the nanobiocomplex and suggests that the cells were eliminated by the ROS produced by the photoexcited TiO 2 -NPs. As described before, excessive ROS can induce cell elimination through several death pathways. The highest cytotoxic effect was observed with 50 mg bound DLDH RGD to 5 mg A-NPs (1 : 100 ratio), a combination at which we have documented that 90% of the protein is bound to the TiO 2 NPs. These results suggest that at this nanaobiocomplex ratio an optimal integrin-targeted delivery by the DLDH RGD of the TiO 2 NPs is documented. Thus, subsequent experiments were conducted with this specic combination. setting was conducted in normal cells which lack avb3 integrin expression (HEK293, 48 Fig. S-3 †) . The treated cells were illuminated by UVA for an hour. As controls, cells treated in the same manner were kept in the dark. Following illumination, the cells were kept overnight in a biological incubator. The next day, the cells were stained with a nuclear dye (Draq5) and visualized using confocal microscopy. Results indicate that in the absence of photoactivation, no effect on cell density or morphology was observed for all detailed treatments in both the melanoma (Fig. 4A, upper panel) and control cells (Fig. 4A, lower panel) . These results indicate that in the absence of illumination, conditions in which TiO 2 is not activated, no cytotoxic outcome is anticipated.
Following photoexcitation, A-NPs alone or bound to native DLDH produced a comparable cytotoxic effect in melanoma cells (Fig. 4B, upper panel) . Notably, this cytotoxic effect by the A-NPs, was potently enhanced in the presence of the modied (Fig. 4B, lower panel) , a comparable cytotoxic effect was documented by TiO 2 alone or in the presence of native or RGDmodied DLDH. Next, the same experiment underwent analysis for absolute cell counts under dark conditions (Fig. 4C ) or following illumination (Fig. 4D) Several in vitro and in vivo studies, in which TiO 2 nanoparticles or nanotubes were assessed as potential anti-cancer treatments were published, mainly in cervical and skin cancers. [10] [11] [12] [13] [14] In all of these works, however, cytotoxicity was induced in up to half of the cells, the value that was obtained by us with TiO 2 nanoparticles alone. While using our novel TiO 2 -DLDH RGD nanobiocomplex, greatly enhanced the cytotoxic effect. In addition, the illumination time needed in our experimental settings to produce an effect was usually shorter. Lastly, it is pertinent to note that the approach of using TiO 2 as a single agent is limited by the inability of the TiO 2 -emitted ROS to distinguish between normal and cancer cells.
13,14
In recent years, studies on integrins which, in contrast to normal cells, are highly expressed on the surface of cancer cells, have ignited renewed interest in integrin-targeted-delivery, mainly via the specic recognition site for the three-peptide ligand RGD. 49, 50 By using TiO 2 integrin-targeted-delivery, we have produced an effect that was cancer-specic. Similar attempts have been done to selectively deliver the TiO 2 particles via an RGD-recognition site. 28, [51] [52] [53] [54] [55] Other approaches to target the TiO 2 directly to cancer cells, sparing harmful effects in normal tissues, are under active research. Such targeteddelivery, for example, includes the attachment of TiO 2 to an antibody recognizing colon-cancer specic antigen. 56 However, most of these TiO 2 conjugates require complex synthetic chemical steps.
Conclusions
The goal of this research was to develop an integrin-targeted nanomedicine for PDT. By modifying DLDH, a TiO 2 binding protein, with RGD moieties, we have generated a nanobiocomplex that is UVA switchable, highly selective towards cancer cells and effective in producing cell death. We propose that this hybrid-conjugate TiO 2 -DLDH RGD may serve as a novel targeted therapeutic agent with relevance to several integrinexpressing tumor models.
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